1. In vivo distribution of [¹¹C]-busulfan incynomolgus monkey and in the brain of a human patient

   • Moustapha Hassan
   • Gunnar öberg
   • Lennart Widén

   Original Articles Pages: 81 - 85

2. Toxicity and metabolism of 3′-deoxyadenosine N¹-oxide in mice and Ehrlich ascites tumor cells

   • Karsten Ramløv Svendsen
   • Kay Overgaard-Hansen
   • Lars Lindhardt Vindeløv

   Original Articles Pages: 86 - 94

3. Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529

   • Cristiana Agen
   • Nunzia Bernardini
   • Mario Del Tacca

   Original Articles Pages: 95 - 99

4. Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma

   • Tom A. Wiklund
   • Carl P. Blomqvist
   • Inkeri Elomaa

   Original Articles Pages: 100 - 104

5. Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations

   • Jochem Kötting
   • Martin R. Berger
   • Hansjörg Eibl

   Original Articles Pages: 105 - 112

6. Chemosensitivity of human MCF-7 breast cancer cells to diastereoisomeric diaqua(1,2-diphenylethylenediamine) platinum(II) sulfates and specific platinum accumulation

   • Herta Reile
   • Günther Bernhardt
   • Franz Lux

   Original Articles Pages: 113 - 122

7. Doxorubicin inhibits human DNA topoisomerase I

   • P. David Foglesong
   • Calvin Reckord
   • Sharon Swink

   Original Articles Pages: 123 - 125

8. Phenotypic analysis of 1-B-d-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response

   • W. Kreis
   • M. Lesser
   • S. Akerman

   Original Articles Pages: 126 - 130

9. Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines

   • A. Galeano
   • M. R. Berger
   • B. K. Keppler

   Original Articles Pages: 131 - 138

10. The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3′-amino-2′,3′-dideoxycytidine and cytosine arabinoside

    • William R. Mancini

    Original Articles Pages: 139 - 144

11. Effect of a low-protein diet on doxorubicin pharmacokinetics in the rabbit

    • Barry J. Cusack
    • Stephan P. Young
    • Richard D. Olson

    Original Articles Pages: 145 - 148

12. Gut protection by cyclophosphamide “priming” in patients receiving high-dose melphalan — effect of drug scheduling

    • Janine Mansi
    • Elisabeth Ellis
    • David Cunningham

    Short Communication Pages: 149 - 151

13. Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro

    • Kathryn Osann
    • Paula Sweet
    • Lewis M. Slater

    Short Communication Pages: 152 - 154

14. A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia

    • Peter C. Adamson
    • Solomon Zimm
    • David G. Poplack

    Short Communication Pages: 155 - 157

15. Bleomycin lung: the effect of different chemotherapeutic regimens

    • R. A. Chisholm
    • A. K. Dixon
    • R. T. D. Oliver

    Short Communication Pages: 158 - 160

16. Pilot study of escalating doses of carboplatin and cyclophosphamide in patients with advanced cancer

    • Russell L. Basser
    • Michael D. Green
    • Richard M. Fox

    Short Communication Pages: 161 - 163

17. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier

    • Yoshiaki Takada
    • Nigel H. Greig
    • Quentin R. Smith

    Erratum Pages: 164 - 164

18. Meeting announcements

    Announcement Pages: 165 - 165